Lyell Immunopharma (LYEL) Earnings Date & Reports

Lyell Immunopharma Inc is a clinical-stage cell therapy company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LYEL is expected to report earnings to fall 75.89% to -17 cents per share on May 13

Lyell Immunopharma LYEL Stock Earnings Reports

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.51

Q3'24

Beat

by $0.01

Q2'24

Est.

$-0.18

Q1'24

Missed

by $0.02

The last earnings report on March 12 showed earnings per share of -70 cents, missing the estimate of -19 cents. With 612.64K shares outstanding, the current market capitalization sits at 132.96M.

View a ticker or compare two or three

Compare

LYEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LYEL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

201 Haskins Way

Phone

+1 650 695-0677

Employees

224

Web

https://www.lyell.com